Maureen Dubreuil, MD MSc
@spondymd.bsky.social
Spondyloarthritis-focused Rheumatologist
Boston U School of Med | VA Boston
https://www.bumc.bu.edu/camed/profile/maureen-dubreuil/
Boston U School of Med | VA Boston
https://www.bumc.bu.edu/camed/profile/maureen-dubreuil/
Reposted by Maureen Dubreuil, MD MSc
🧵 New study alert!
💊 Does early TNF inhibitor (TNFi) therapy reduce chronic opioid use in axial spondyloarthritis (axSpA)?
👉 We looked at real-world US data to find out.
📄 Arthritis Care & Research, 2025
🔗 acrjournals.onlinelibrary.wiley.com/doi/10.1002/...
@rheumcat.bsky.social
💊 Does early TNF inhibitor (TNFi) therapy reduce chronic opioid use in axial spondyloarthritis (axSpA)?
👉 We looked at real-world US data to find out.
📄 Arthritis Care & Research, 2025
🔗 acrjournals.onlinelibrary.wiley.com/doi/10.1002/...
@rheumcat.bsky.social
October 14, 2025 at 3:15 PM
🧵 New study alert!
💊 Does early TNF inhibitor (TNFi) therapy reduce chronic opioid use in axial spondyloarthritis (axSpA)?
👉 We looked at real-world US data to find out.
📄 Arthritis Care & Research, 2025
🔗 acrjournals.onlinelibrary.wiley.com/doi/10.1002/...
@rheumcat.bsky.social
💊 Does early TNF inhibitor (TNFi) therapy reduce chronic opioid use in axial spondyloarthritis (axSpA)?
👉 We looked at real-world US data to find out.
📄 Arthritis Care & Research, 2025
🔗 acrjournals.onlinelibrary.wiley.com/doi/10.1002/...
@rheumcat.bsky.social
Reposted by Maureen Dubreuil, MD MSc
Our paper looking at annual prescription rates of opioids 💊 vs NSAIDs 💊and TNF inhibitors 💉for people with axial spondyloarthritis in the US & UK is now out @acr-journals.bsky.social
pubmed.ncbi.nlm.nih.gov/40977482/
@degirmenciberk2.bsky.social is preparing a visual abstract, so stay tuned
pubmed.ncbi.nlm.nih.gov/40977482/
@degirmenciberk2.bsky.social is preparing a visual abstract, so stay tuned
Trends in Opioid Prescriptions in Individuals with Axial Spondyloarthritis in the US and UK in the Last Two Decades: Analysis of Electronic Health Records and Insurance Claims Data - PubMed
Opioid prescriptions rates remained stable over time in the UK, while they slightly decreased in the US as TNFi uptake increased. These trends may reflect a US nationwide change in guidance for opioid...
pubmed.ncbi.nlm.nih.gov
September 22, 2025 at 5:57 PM
Our paper looking at annual prescription rates of opioids 💊 vs NSAIDs 💊and TNF inhibitors 💉for people with axial spondyloarthritis in the US & UK is now out @acr-journals.bsky.social
pubmed.ncbi.nlm.nih.gov/40977482/
@degirmenciberk2.bsky.social is preparing a visual abstract, so stay tuned
pubmed.ncbi.nlm.nih.gov/40977482/
@degirmenciberk2.bsky.social is preparing a visual abstract, so stay tuned
We at BU Rheum had the pleasure of learning from Drs. Divya Shankar and Mari-Lynn Drainone to speak today on Implementation Science. sites.bu.edu/ciis/ @bu-bmc-rheum.bsky.social
CIIS
sites.bu.edu
September 23, 2025 at 3:16 PM
We at BU Rheum had the pleasure of learning from Drs. Divya Shankar and Mari-Lynn Drainone to speak today on Implementation Science. sites.bu.edu/ciis/ @bu-bmc-rheum.bsky.social
We found that adults with axSpA or PsA had ⬇️ odds of hip/knee replacement with use ofTNFi, non-TNFi biologics or DMARDs as compared to NSAIDs. Odds w/ JAK inhib was also lower but not statistically significant. Use this info in shared decision-making!
New publication from @bu-bmc-rheum.bsky.social with IM resident Angela Achkar and senior mentor @spondymd.bsky.social:
Targeted and biologic therapies and risk of total knee or hip replacement in axial spondyloarthritis and psoriatic arthritis - Clinical Rheumatology
Background Axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA) are chronic inflammatory diseases that often cause joint damage, potentially leading to joint replacement surgery. We assessed ...
links.springernature.com
September 12, 2025 at 12:33 AM
We found that adults with axSpA or PsA had ⬇️ odds of hip/knee replacement with use ofTNFi, non-TNFi biologics or DMARDs as compared to NSAIDs. Odds w/ JAK inhib was also lower but not statistically significant. Use this info in shared decision-making!
Veterans I care for at VA Boston showed me so much love today with tasty treats! Incredible tomatoes, spaghetti & meatballs and homemade BBQ sauce! @vaboston.bsky.social
September 11, 2025 at 9:48 PM
Veterans I care for at VA Boston showed me so much love today with tasty treats! Incredible tomatoes, spaghetti & meatballs and homemade BBQ sauce! @vaboston.bsky.social
This is critically important to our understanding of SpA!
Panorama
Enhancing Genetic Studies on Rheumatic Diseases in Latin America: The IARGE-RD Initiative
📖 doi.org/10.3899/jrhe...
#geneticresearch #rheumaticdiseases #latinamerica #caribbean
Enhancing Genetic Studies on Rheumatic Diseases in Latin America: The IARGE-RD Initiative
📖 doi.org/10.3899/jrhe...
#geneticresearch #rheumaticdiseases #latinamerica #caribbean
June 17, 2025 at 6:12 PM
This is critically important to our understanding of SpA!
The SPARTAN Review Course is on! Dr. Aki Nakamura presented on the pathogenesis of axial spondyloarthritis, highlighting new science around HLA-B27, arthritogenic peptides and mechanisms of disease independent of HLA-B27. deptmed.queensu.ca/index.php/pe...
May 8, 2025 at 7:49 PM
The SPARTAN Review Course is on! Dr. Aki Nakamura presented on the pathogenesis of axial spondyloarthritis, highlighting new science around HLA-B27, arthritogenic peptides and mechanisms of disease independent of HLA-B27. deptmed.queensu.ca/index.php/pe...
💫As part of our T32 lecture series @bu-bmc-rheum.bsky.social welcomed Drs. Sarah Bagley (GIM) and Vanessa Xanthakis (Preventive Med) to discuss LIFE HACKS FOR BUSY RESEARCHERS. Highlights here. Do you have any tips to share? www.bumc.bu.edu/rheumatology...
May 6, 2025 at 3:12 PM
💫As part of our T32 lecture series @bu-bmc-rheum.bsky.social welcomed Drs. Sarah Bagley (GIM) and Vanessa Xanthakis (Preventive Med) to discuss LIFE HACKS FOR BUSY RESEARCHERS. Highlights here. Do you have any tips to share? www.bumc.bu.edu/rheumatology...
Today we learned from osteoporosis expert Dr. Alan Malabanan about management of patients at very high risk for fracture. @alanmalabanan.bsky.social www.bumc.bu.edu/medicine/pro...
Alan Malabanan | Medicine
www.bumc.bu.edu
April 30, 2025 at 3:57 PM
Today we learned from osteoporosis expert Dr. Alan Malabanan about management of patients at very high risk for fracture. @alanmalabanan.bsky.social www.bumc.bu.edu/medicine/pro...
🌏The 7th Annual Global Spondyloarthritis Summit is May 2nd & 3rd! Enjoy interactive activities, rooms, networking, gamification, exercise and yoga classes, poster hall, exhibit hall, swag bags, social media wall and more. spondyloarthritissummit2025.vfairs.com
SAA Global Spondyloarthritis Summit 2025
spondyloarthritissummit2025.vfairs.com
April 28, 2025 at 10:40 AM
🌏The 7th Annual Global Spondyloarthritis Summit is May 2nd & 3rd! Enjoy interactive activities, rooms, networking, gamification, exercise and yoga classes, poster hall, exhibit hall, swag bags, social media wall and more. spondyloarthritissummit2025.vfairs.com
Reposted by Maureen Dubreuil, MD MSc
Editor's Picks Spotlight
Disparities in Time to Diagnosis of Radiographic Axial Spondyloarthritis with Drs. Renato Ferrandiz-Espadin, Jean W. Liew and Maureen Dubreuil
@renatoferrandiz.bsky.social @rheumcat.bsky.social
@spondymd.bsky.social
📖 doi.org/10.3899/jrhe...
📽️ youtu.be/jXAe-dlbxsc
Disparities in Time to Diagnosis of Radiographic Axial Spondyloarthritis with Drs. Renato Ferrandiz-Espadin, Jean W. Liew and Maureen Dubreuil
@renatoferrandiz.bsky.social @rheumcat.bsky.social
@spondymd.bsky.social
📖 doi.org/10.3899/jrhe...
📽️ youtu.be/jXAe-dlbxsc
Editor's Picks Spotlight: Disparities in Time to Diagnosis of r-axSpA
YouTube video by The Journal of Rheumatology
youtu.be
April 25, 2025 at 4:02 PM
Editor's Picks Spotlight
Disparities in Time to Diagnosis of Radiographic Axial Spondyloarthritis with Drs. Renato Ferrandiz-Espadin, Jean W. Liew and Maureen Dubreuil
@renatoferrandiz.bsky.social @rheumcat.bsky.social
@spondymd.bsky.social
📖 doi.org/10.3899/jrhe...
📽️ youtu.be/jXAe-dlbxsc
Disparities in Time to Diagnosis of Radiographic Axial Spondyloarthritis with Drs. Renato Ferrandiz-Espadin, Jean W. Liew and Maureen Dubreuil
@renatoferrandiz.bsky.social @rheumcat.bsky.social
@spondymd.bsky.social
📖 doi.org/10.3899/jrhe...
📽️ youtu.be/jXAe-dlbxsc
💡 We recently had the pleasure of learning from my colleague, Dr. Monica Crespo-Bosque, who discussed Treatment of Arthritis in Lupus. www.bumc.bu.edu/camed/profil...
Monica Crespo-Bosque | Chobanian & Avedisian School of Medicine
www.bumc.bu.edu
April 9, 2025 at 3:33 PM
💡 We recently had the pleasure of learning from my colleague, Dr. Monica Crespo-Bosque, who discussed Treatment of Arthritis in Lupus. www.bumc.bu.edu/camed/profil...
Congrats to Deepak Kumar sites.bu.edu/kumarlab/ who found that earlier PT and >12 sessions were associated with lower risk of future intra-articular therapy use in people w/ knee OA. doi.org/10.1002/art....
April 3, 2025 at 1:52 AM
Congrats to Deepak Kumar sites.bu.edu/kumarlab/ who found that earlier PT and >12 sessions were associated with lower risk of future intra-articular therapy use in people w/ knee OA. doi.org/10.1002/art....
Reposted by Maureen Dubreuil, MD MSc
Excited to share our latest publication on demographic & geographic diversity in axial spondyloarthritis drug trials!
We analyzed 59 trials (16,000+ participants) since 2000.
Big thanks to the team @wissamghusn.bsky.social @spondymd.bsky.social @joergermann
pubmed.ncbi.nlm.nih.gov/40089303/
We analyzed 59 trials (16,000+ participants) since 2000.
Big thanks to the team @wissamghusn.bsky.social @spondymd.bsky.social @joergermann
pubmed.ncbi.nlm.nih.gov/40089303/
Diversity in Axial Spondyloarthritis Drug Trials: Enrollment by Sex, Race, Ethnicity, and Geographic Region - PubMed
The enrollment of women in axSpA drug trials largely reflects disease demographics. Race and ethnicity reporting has improved over time. While participation of Asian, American Indian/Alaska Native and...
pubmed.ncbi.nlm.nih.gov
April 1, 2025 at 2:40 PM
Excited to share our latest publication on demographic & geographic diversity in axial spondyloarthritis drug trials!
We analyzed 59 trials (16,000+ participants) since 2000.
Big thanks to the team @wissamghusn.bsky.social @spondymd.bsky.social @joergermann
pubmed.ncbi.nlm.nih.gov/40089303/
We analyzed 59 trials (16,000+ participants) since 2000.
Big thanks to the team @wissamghusn.bsky.social @spondymd.bsky.social @joergermann
pubmed.ncbi.nlm.nih.gov/40089303/
We found that diagnostic delay in axial spondyloarthritis was 21% longer (7 months) among people with a social need, using an accelerated failure time model. @jrheumatol.bsky.social @renatoferrandiz.bsky.social www.jrheum.org/content/52/4...
Disparities in Time to Diagnosis of Radiographic Axial Spondyloarthritis
Objective Radiographic axial spondyloarthritis (r-axSpA) has a 7-year average diagnostic delay. Although the effects of sex or gender on time to diagnosis have been evaluated, the role of social deter...
www.jrheum.org
April 1, 2025 at 2:21 PM
We found that diagnostic delay in axial spondyloarthritis was 21% longer (7 months) among people with a social need, using an accelerated failure time model. @jrheumatol.bsky.social @renatoferrandiz.bsky.social www.jrheum.org/content/52/4...
We had the pleasure of learning from Dr. Robert John Fontana today about liver injury related to DMARDs and other rheum meds #rheumsky www.michiganmedicine.org/profile/3966...
Robert J. Fontana
www.michiganmedicine.org
March 5, 2025 at 5:16 PM
We had the pleasure of learning from Dr. Robert John Fontana today about liver injury related to DMARDs and other rheum meds #rheumsky www.michiganmedicine.org/profile/3966...
Our study was covered by Healio: TNFi were associated with 29% lower odds of fracture relative to NSAIDs in axSpA!
www.healio.com/news/rheumat...
www.healio.com/news/rheumat...
TNF inhibitors may reduce fracture risk 29% vs NSAIDs in axial spondyloarthritis
TNF inhibitors for the treatment of axial spondyloarthritis may decrease the risk for hip or spine fracture by as much as 29% compared with NSAIDs, according to data published in Arthritis & Rheum...
www.healio.com
February 20, 2025 at 10:25 PM
Our study was covered by Healio: TNFi were associated with 29% lower odds of fracture relative to NSAIDs in axSpA!
www.healio.com/news/rheumat...
www.healio.com/news/rheumat...
I just came across *3 messages* I sent myself in the middle of the night with additional thoughts on a sick person I recently cared for. #Rheumsky
February 16, 2025 at 6:41 PM
I just came across *3 messages* I sent myself in the middle of the night with additional thoughts on a sick person I recently cared for. #Rheumsky
Reposted by Maureen Dubreuil, MD MSc
February 4, 2025 at 12:07 AM
Last week I visited the Anne Frank House- I urge you to visit, too. On this Holocaust Remembrance Day and every day, we stand against hatred.
January 28, 2025 at 2:23 AM
Last week I visited the Anne Frank House- I urge you to visit, too. On this Holocaust Remembrance Day and every day, we stand against hatred.
SPARTAN's call for trainee abstracts in #spondyloarthritis is out. Due Feb 28. Annual Meeting May 9 & 10 in Toronto. (review course May 8) spartangroup.org/call-for-202...
January 24, 2025 at 1:22 AM
SPARTAN's call for trainee abstracts in #spondyloarthritis is out. Due Feb 28. Annual Meeting May 9 & 10 in Toronto. (review course May 8) spartangroup.org/call-for-202...
SPARTAN Announced $10,000 Mentored Fellowship Award for rheumatology trainees to fund #spondyloarthritis research projects.
Awards announced at the SPARTAN. Membership not required.
Due Feb 28. spartangroup.org/mentored-fel...
Awards announced at the SPARTAN. Membership not required.
Due Feb 28. spartangroup.org/mentored-fel...
January 24, 2025 at 1:19 AM
SPARTAN Announced $10,000 Mentored Fellowship Award for rheumatology trainees to fund #spondyloarthritis research projects.
Awards announced at the SPARTAN. Membership not required.
Due Feb 28. spartangroup.org/mentored-fel...
Awards announced at the SPARTAN. Membership not required.
Due Feb 28. spartangroup.org/mentored-fel...
SPARTAN announced a $25,000 Early Career Investigator Award for members. Due Feb 28.
t.co/k232lhj2uw
t.co/k232lhj2uw
https://spartangroup.org/early-career-investigator-award/
t.co
January 24, 2025 at 1:17 AM
SPARTAN announced a $25,000 Early Career Investigator Award for members. Due Feb 28.
t.co/k232lhj2uw
t.co/k232lhj2uw
Reposted by Maureen Dubreuil, MD MSc
If you’ve been directly impacted by a pause or cancellation of an NIH study session, we @forbes.com would like to talk to you
All NIH study sections canceled indefinitely. This will halt science and devastate research budgets in universities.
January 22, 2025 at 10:59 PM
If you’ve been directly impacted by a pause or cancellation of an NIH study session, we @forbes.com would like to talk to you